SPRAVATO® is an FDA-approved nasal spray specifically designed to help adults with:
Unlike conventional antidepressants, which may take weeks to show results, SPRAVATO® has demonstrated rapid improvements in depressive symptoms, often within 24 hours.
SPRAVATO® takes a novel approach to managing depression. Administered under the supervision of a healthcare provider, this nasal spray targets NMDA receptors in the brain to deliver quick and significant symptom relief. Patients receive SPRAVATO® in a certified treatment center where they are closely monitored for at least two hours post-administration.
Begin with a complimentary phone consultation, followed by an in-depth evaluation by our mental health professionals. This includes reviewing your medical history and treatment needs to confirm eligibility for Spravato. If eligible, we verify your insurance coverage, working with major providers.
Once approved, your initial SPRAVATO® session is scheduled. Treatments are administered in our clinic under strict medical supervision. You self-administer the nasal spray in a calm, controlled environment and are monitored for at least two hours to ensure safety and address any side effects.
Your treatment plan begins with an induction phase, typically involving twice-weekly sessions. Over time, this transitions to a maintenance phase with less frequent treatments, customized to your unique mental health goals.
Our team remains by your side throughout your journey, offering regular follow-ups to monitor progress and address concerns. We adjust your treatment plan as needed, coordinate with your referring provider, and ensure you have the resources for sustained mental health improvement.
Week 1-4
2 Treatments a Week
Week 5+
1 Treatment a Week
Week 9+
1 Treatment a Week Every 1-2 Weeks
Response Rate: Traditional antidepressants typically achieve a response rate of 40-60%, while SPRAVATO® has demonstrated response rates of up to 70%.
Time to Noticeable Effect: Traditional antidepressants often take 4-6 weeks for noticeable improvements, whereas patients using SPRAVATO® (esketamine) may experience relief within 24 hours.
Sustained Remission Rate: Traditional antidepressants achieve sustained remission rates of 15-30%, but SPRAVATO® has shown sustained rates of up to 80%.
At Allevate Health, we combine cutting-edge psychiatric treatments with personalized care to support long-term healing.
Every treatment we offer, including SPRAVATO®, is backed by clinical research and administered in a structured, safe setting.
We work closely with your existing care team to ensure a comprehensive mental health support system.
We’re in-network with most major insurers and offer flexible scheduling to make care as accessible as possible.
Transformation: What People Who Finally Found Relief With SPRAVATO® Have to Say
Explore the inspiring journeys of individuals who have transformed their lives through the clinical use of SPRAVATO®. From overcoming obstacles to reaching significant milestones, these individuals share how SPRAVATO® treatment has been instrumental in reshaping their habits and creating lasting change. Discover real-life stories of success, motivation, and the powerful impact of building sustainable habits for a better life.
Tell your provider about all medications and supplements you’re taking, including any history of substance use or mental health disorders. Be sure to mention if you are pregnant, plan to become pregnant, or are breastfeeding.
SPRAVATO® is FDA-approved, intranasal esketamine, with a defined dosage and insurance coverage. IV ketamine is administered off-label and typically paid out-of-pocket.
No. SPRAVATO® must be administered in a certified treatment center under medical supervision due to potential side effects and required monitoring.
SPRAVATO® is not recommended during pregnancy or while breastfeeding. Talk to your healthcare provider about risks and alternative treatments.
You should not use SPRAVATO® if you have a history of aneurysms, bleeding in the brain, or allergic reactions to esketamine. It’s also not suitable for individuals with certain substance use disorders.
Your provider will monitor your mood, behavior, and overall mental health across sessions to evaluate progress and adjust your treatment plan as needed.
It is very important to make every effort to stay on the treatment plan that you and your healthcare provider have made. However, if you do miss a treatment, contact your healthcare provider as soon as possible to discuss how to get back on track. You may need to reschedule missed appointments, receive an additional treatment, or make other adjustments. Your provider may decide to change your dose or dosing frequency.
Yes. Keep all members of your healthcare team informed about your SPRAVATO® treatment to avoid medication interactions and ensure coordinated care.
Possibly, but your blood pressure must be carefully monitored before and after treatment. Your provider will determine if SPRAVATO® is appropriate for you.
Yes. SPRAVATO® can interact with sedatives, benzodiazepines, stimulants, and other medications. Inform your provider about everything you’re taking.
You should avoid eating for at least 2 hours and drinking liquids for 30 minutes before treatment to reduce the risk of nausea.
Avoid driving, operating machinery, or making important decisions for the rest of the day. Arrange for someone to drive you home.
No. You must not drive or operate heavy machinery until the next day after a restful sleep.
Call us at 640-252-9785 or
complete the form below.
